A client who has Graves' disease is prescribed methimazole.
Which of the following effects should the nurse expect to see after the client has taken the medication for 2 months?
Weight loss.
Warmer skin.
Increase in pulse rate.
Increased sleeping.
The Correct Answer is D
Methimazole is an antithyroid medication that controls the overproduction of thyroid hormone in Graves’ disease.
One of the symptoms of Graves’ disease is difficulty sleeping due to the overproduction of thyroid hormone.
After taking methimazole for 2 months, the client’s thyroid hormone levels should decrease, leading to an improvement in sleep.
Choice A is wrong because weight loss is a symptom of Graves’ disease due to the overproduction of thyroid hormone.
Methimazole controls the overproduction of thyroid hormone and may lead to weight gain.
Choice B is wrong because warmer skin is a symptom of Graves’ disease due to the overproduction of thyroid hormone.
Methimazole controls the overproduction of thyroid hormone and may lead to cooler skin.
Choice C is wrong because an increase in pulse rate is a symptom of Graves’ disease due to the overproduction of thyroid hormone.
Methimazole controls the overproduction of thyroid hormone and may lead to a decrease in pulse rate.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale: Administering filgrastim after chemotherapy is a standard practice to boost white blood cell count. However, filgrastim should not be given within 24 hours before or after chemotherapy, as it can affect the efficacy and increase the risk of side effects. Administering the medication 12 hours after chemotherapy falls within this contraindicated window, necessitating an incident report.
Choice B rationale: Filgrastim can be stored at room temperature for short periods, and 2 hours is generally within acceptable limits for stability.
Choice C rationale: An absolute neutrophil count of 2,500/mm³ is within the normal range, and there is no contraindication for administering filgrastim.
Choice D rationale: Flushing the client's IV line with dextrose 5% in water before and after administering filgrastim is not appropriate, as this medication is typically administered with saline solution. Using an incorrect flushing solution could affect the medication's efficacy or compatibility, necessitating an incident report.
Correct Answer is D
Explanation
A client who has deep-vein thrombosis and is taking warfarin should obtain an International Normalized Ratio (INR) test monthly.
This blood test measures how fast the blood clots and helps the healthcare provider determine if the client is taking the right dose of warfarin to keep them safe from bleeding and making clots.
Choice A is wrong because Platelet count, is not the correct answer because it measures the number of platelets in the blood and is not specifically related to warfarin therapy.
Choice B is wrong because aPTT, is not the correct answer because it measures the time it takes for blood to clot and is used to monitor heparin therapy, not warfarin therapy.
Choice C is wrong because Fibrinogen, is not the correct answer because it measures the amount of fibrinogen in the blood and is not specifically related to warfarin therapy.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today